Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:588-593
doi: 10.1161/hc3101.092213
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, P.-Y.
Right arrow Articles by Chen, C.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, P.-Y.
Right arrow Articles by Chen, C.-H.
Related Collections
Right arrow Lipid and lipoprotein metabolism
Right arrow Angiogenesis
Right arrow Gene regulation
Right arrow Genomics

(Circulation. 2001;104:588.)
© 2001 American Heart Association, Inc.


Basic Science Reports

Oxidized Low-Density Lipoprotein Downregulates Endothelial Basic Fibroblast Growth Factor Through a Pertussis Toxin-Sensitive G-Protein Pathway

Mediator Role of Platelet-Activating Factor-Like Phospholipids

Po-Yuan Chang, MD, PhD; Sherry Luo, BS; Tao Jiang, PhD; Yuan-Teh Lee, MD, PhD; Shao-Chun Lu, PhD; Philip D. Henry, MD; Chu-Huang Chen, MD, PhD

From the Department of Medicine, Baylor College of Medicine, Houston, Tex (P.-Y.C., S.L., T.J., P.D.H., C.-H.C.); and the Departments of Internal Medicine (P.-Y.C., Y.-T.L.) and Biochemistry (S.-C.L.), National Taiwan University Medical School, Taipei, Taiwan.

Correspondence to Chu-Huang Chen, MD, PhD, MS A-601, Department of Medicine, Baylor College of Medicine, 6565 Fannin, Houston, TX 77030. E-mail cchen{at}bcm.tmc.edu

Background— Oxidized LDL (oxLDL) inhibits angiogenesis in part by downregulating endothelial basic fibroblast growth factor (bFGF). To determine the mechanism of the downregulation, we investigated the signal transduction pathway involving potential phospholipid mediators.

Methods and Results— Cultured bovine aortic endothelial cells were incubated with PBS (lipoprotein-free control), LDL, or copper oxLDL under serum-free conditions. At 24 hours, oxLDL (50 µg/mL) decreased bFGF mRNA (Northern blot), bFGF protein (Western blot and ELISA), and concomitant DNA synthesis, all by 40% to 50% compared with PBS. LDL had no effect. Pretreating the cells with 100 ng/mL pertussis toxin (PTX) for 18 hours before oxLDL exposure almost completely blocked the inhibitory effects of oxLDL. In contrast, inhibiting other major cellular signal transduction pathways with PD-98059 (mitogen-activated protein kinase kinase inhibitor), HA-1004 (inhibitor of cGMP- and cAMP-dependent protein kinase), or Ro-31-8220 (protein kinase C inhibitor) or chelating intracellular Ca2+ with BAPTA-AM failed to attenuate any of the oxLDL effects assayed. Addition to the cultures of WEB 2086, a specific antagonist of the PTX-sensitive G protein–coupled platelet-activating factor (PAF) receptor, blocked the action of oxLDL. Whereas PAF dispersed in the culture medium failed to produce oxLDL-like effects, degradation of PAF and PAF-like phospholipids accumulated in oxLDL with a recombinant human PAF acetylhydrolase eliminated the inhibitory effects of oxLDL on bFGF expression and DNA synthesis.

Conclusions— OxLDL suppresses endothelial bFGF expression and DNA synthesis through a PTX-sensitive heterotrimeric G-protein pathway involving mediator phospholipids similar, but not identical, to PAF.


Key Words: phospholipids • lipoproteins • growth substances • endothelium • genes




This article has been cited by other articles:


Home page
Circ. Res.Home page
P.-Y. Chang, S.-C. Lu, C.-M. Lee, Y.-J. Chen, T. A. Dugan, W.-H. Huang, S.-F. Chang, W. S.L. Liao, C.-H. Chen, and Y.-T. Lee
Homocysteine Inhibits Arterial Endothelial Cell Growth Through Transcriptional Downregulation of Fibroblast Growth Factor-2 Involving G Protein and DNA Methylation
Circ. Res., April 25, 2008; 102(8): 933 - 941.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Lu, W. Jiang, J.-H. Yang, P.-Y. Chang, J. P. Walterscheid, H.-H. Chen, M. Marcelli, D. Tang, Y.-T. Lee, W. S.L. Liao, et al.
Electronegative LDL Impairs Vascular Endothelial Cell Integrity in Diabetes by Disrupting Fibroblast Growth Factor 2 (FGF2) Autoregulation
Diabetes, January 1, 2008; 57(1): 158 - 166.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Dandapat, C. Hu, L. Sun, and J. L. Mehta
Small Concentrations of oxLDL Induce Capillary Tube Formation From Endothelial Cells via LOX-1 Dependent Redox-Sensitive Pathway
Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2435 - 2442.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C.-H. Chen and J. P. Walterscheid
Plaque Angiogenesis Versus Compensatory Arteriogenesis in Atherosclerosis
Circ. Res., October 13, 2006; 99(8): 787 - 789.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. F. Khalil, W. D. Wagner, and I. J. Goldberg
Molecular Interactions Leading to Lipoprotein Retention and the Initiation of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2211 - 2218.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P.-Y. Chang, S.-C. Lu, T.-C. Su, S.-F. Chou, W.-H. Huang, J. D. Morrisett, C.-H. Chen, C.-S. Liau, and Y.-T. Lee
Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation
J. Lipid Res., November 1, 2004; 45(11): 2116 - 2122.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Jozefowski and L. Kobzik
Scavenger receptor A mediates H2O2 production and suppression of IL-12 release in murine macrophages
J. Leukoc. Biol., November 1, 2004; 76(5): 1066 - 1074.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Benndorf, R. H. Boger, S. Ergun, A. Steenpass, and T. Wieland
Angiotensin II Type 2 Receptor Inhibits Vascular Endothelial Growth Factor-Induced Migration and In Vitro Tube Formation of Human Endothelial Cells
Circ. Res., September 5, 2003; 93(5): 438 - 447.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C.-H. Chen, T. Jiang, J.-H. Yang, W. Jiang, J. Lu, G. K. Marathe, H. J. Pownall, C. M. Ballantyne, T. M. McIntyre, P. D. Henry, et al.
Low-Density Lipoprotein in Hypercholesterolemic Human Plasma Induces Vascular Endothelial Cell Apoptosis by Inhibiting Fibroblast Growth Factor 2 Transcription
Circulation, April 29, 2003; 107(16): 2102 - 2108.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Mertens, P. Verhamme, J. K. Bielicki, M. C. Phillips, R. Quarck, W. Verreth, D. Stengel, E. Ninio, M. Navab, B. Mackness, et al.
Increased Low-Density Lipoprotein Oxidation and Impaired High-Density Lipoprotein Antioxidant Defense Are Associated With Increased Macrophage Homing and Atherosclerosis in Dyslipidemic Obese Mice: LCAT Gene Transfer Decreases Atherosclerosis
Circulation, April 1, 2003; 107(12): 1640 - 1646.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. L. Balestrieri, D. Castaldo, C. Balestrieri, L. Quagliuolo, A. Giovane, and L. Servillo
Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress
J. Lipid Res., February 1, 2003; 44(2): 380 - 387.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
T. S. Sherman, K. L. Chambliss, L. L. Gibson, M. C. Pace, M. E. Mendelsohn, S. L. Pfister, and P. W. Shaul
Estrogen Acutely Activates Prostacyclin Synthesis in Ovine Fetal Pulmonary Artery Endothelium
Am. J. Respir. Cell Mol. Biol., May 1, 2002; 26(5): 610 - 616.
[Abstract] [Full Text] [PDF]